I am delighted to share the main work of my PhD project in the Hamperl lab now out in @NAR_Open. TRCs drive R-loop-dependent nucleosome eviction and require DOT1L activity for transcription recovery.
https://t.co/4pQJ88zZ6X
Full thread on BlueSky 🦋 @ https://t.co/3GETur47Rd
Online Now: Precise control of transcription condensates across S phase balances linker histone expression with DNA replication, ensuring genome stability https://t.co/O7Ue4Lw1lq
Our paper is finally online in @NatureSMB 🎉we uncovered a transcription regulatory role of promoter-proximal Pol II termination during human cell type transition. Many thanks to everyone involved!!!
https://t.co/TMWWWRrwVK
Happy to share our newly published article in Nature Communications! In this work, we uncover the novel role of KLF5 in sensitizing cells to ATR inhibition, identifying it as a synthetic lethal partner with the tumor suppressor ARID1A. @SPJacksonGroup
https://t.co/0bHKUUitvP
Truly honoured to received such a recognition - a deep, big thanks to current and former people from my lab, our collaborators, our funders and the people who support our work every day
Maria-Elena Torres-Padilla Awarded the Leibniz-Preis 2025 🎉
👏 The German Research Foundation (#DFG) recognizes the outstanding research of Prof. Maria-Elena Torres-Padilla with Germany’s most prestigious scientific award: the Gottfried Wilhelm #LeibnizPreis.
👉https://t.co/BCyal9ZcXk
💡 The international top scientist from #HelmholtzMunich fundamentally changed our understanding of stem cell biology an early development.
With her groundbreaking "cells à la carte" approach, the Mexico-born scientist is pioneering innovative #therapies for diseases like neurodegeneration, brain injuries, and cancer.
👉Discover more in her #interview "Empowering Cells’ and Scientists’ Potential for Cell Therapies":
🔗https://t.co/EiNQHUPRDk
Prof. Matthias Tschöp, CEO of Helmholtz Munich, states:
💬 "Maria-Elena Torres-Padilla has fundamentally changed our understanding of early development and epigenetic regulation with her groundbreaking contributions to stem cell biology. Her scientific excellence and innovative thinking have had a profound impact on the field and inspires researchers worldwide. The Leibniz Prize is a well-deserved recognition of her exceptional achievements and lasting influence on biomedicine."
🌟 Why it matters:
Her work is not just science - it’s the foundation for future #PersonalizedMedicine and #RegenerativeTherapies.
About Maria-Elena Torres-Padilla:
✨Head of the Stem Cell Center (rotating), Helmholtz Munich
✨Director of the Institute of Epigenetics and Stem
Cells, Helmholtz Munich
✨Director of Biomedicine at @PioneerCampus
✨Professor at @LMU_Muenchen@METorresPadilla@dfg_public@epigeneticsHMGU@MatthiasTschop
#Epigenetics #StemCells #Award #Research #ResearchPioneers
🚀 Exciting news! Our latest paper reveals a novel function of HLTF in resolving G4 DNA structures and restraining DNA synthesis to maintain genome stability 🧬🔬https://t.co/jZ3v7OutFS… @KarleneCimprich@30xte
New preprint with @KokicGoran and @SvejstrupLab! We show that STK19 facilitates the clearance of lesion-stalled RNAPII during transcription-coupled DNA repair.
Great teamwork by @dianavandenheu2 , @MartaRodrgzMart, and Paula van der Meer!
https://t.co/fdHjrAu67m
1/5
What if we could universally recombine, insert, delete, or invert any two pieces of DNA?
In back-to-back @Nature papers, we report the discovery of bridge RNAs and 3 atomic structures of the first natural RNA-guided recombinase - a new mechanism for programmable genome design
Our latest paper is out in @GenomeBiology!!! Here we present a method to identify genomewide hotspots where replication forks stall or pause. These sites are associated with increased DNA damage and overlap with breakpoints of cancer rearrangements https://t.co/LPBZIH3RMR